Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-03-2023 | Generalized Seizure | Case report

Enzalutamide

Generalised seizure: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Demir O, et al. A case of castration-resistant metastatic prostate cancer who continued treatment with enzalutamide after epileptic seizure. Journal of Oncology Pharmacy Practice 29: 498-501, No. 2, Mar 2023. Available from: URL: https://journals.sagepub.com/home/OPP Demir O, et al. A case of castration-resistant metastatic prostate cancer who continued treatment with enzalutamide after epileptic seizure. Journal of Oncology Pharmacy Practice 29: 498-501, No. 2, Mar 2023. Available from: URL: https://​journals.​sagepub.​com/​home/​OPP
Metadata
Title
Enzalutamide
Generalised seizure: case report
Publication date
01-03-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-34833-8

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Apixaban

Case report

Nivolumab

Case report

Antineoplastics